Jim Grant: Biotech Most Worrisome Portion Of Stock Market

Jim GrantImage source: CNBC Video Screenshot

“The Fed has its thumb on the scales of our finances,” says Jim Grant of Grant’s Interest Rate Observer, weighing in on Janet Yellen and the Fed’s interest rate policy.

H/T Value investing

For exclusive info on hedge funds and the latest news from value investing world at only a few dollars a month check out ValueWalk Premium right here.

Multiple people interested? Check out our new corporate plan right here (We are currently offering a major discount)

About the Author

Sheeraz Raza
Sheeraz is our COO (Chief - Operations), his primary duty is curating and editing of ValueWalk. He is main reason behind the rapid growth of the business. Sheeraz previously ran a taxation firm. He is an expert in technology, he has over 5.5 years of design, development and roll-out experience for SEO and SEM. - Email: sraza(at)valuewalk.com

Be the first to comment on "Jim Grant: Biotech Most Worrisome Portion Of Stock Market"

Leave a comment

Your email address will not be published.